Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Emergent BioSolutions Inc. (NYSE: EBS) announced today its financial results for the first quarter ended March 31, 2013.
Total revenues for Q1 2013 were $43.1 million as compared to $50.3 million in 2012. In addition, for Q1 2013 the company recorded a net loss of $8.1 million, or $0.22 per share, as compared to a net loss of $6.8 million, or $0.19 per share, in 2012.
Help employers find you! Check out all the jobs and post your resume.
Emergent BioSolutions Inc. (NYSE: EBS) announced today its financial results for the first quarter ended March 31, 2013.
Total revenues for Q1 2013 were $43.1 million as compared to $50.3 million in 2012. In addition, for Q1 2013 the company recorded a net loss of $8.1 million, or $0.22 per share, as compared to a net loss of $6.8 million, or $0.19 per share, in 2012.
Help employers find you! Check out all the jobs and post your resume.
